N2-Trityl Olmesartan Acid CAS 752179-89-8 Purity > 98.0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Ruifu Chemical Supply Olmesartan Medoxomil Intermediates Nrog Cov Khoom Zoo:
Tom ntej: 4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3
Tom ntej: 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Tom ntej: Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Tom ntej: Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1
Tom ntej: Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Tom ntej: Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Tshuaj npe | N2-Trityl Olmesartan Acid |
Synonyms | Trityl Olmesartan Acid (N2);Olmesartan N2-Trityl impurity;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl methyl]-1H-Imidazole-5-Carboxylic Acid;4-(2-Hydroxypropan-2-yl)-2-Propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) methyl)-1H-Imidazole-5-Carboxylic Acid |
CAS Nr | 752179-89-8 |
CAT Number | Qauv: RF-PI1876 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C43H40N6O3 |
Molecular Luj | 688.82 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Powder |
Purity / Analysis Method | > 98.0% (HPLC) |
Poob rau ziab | <1.00% |
Residue ntawm Ignition | <0.50% |
Ib leeg Impurity | <1.00% |
Tag nrho cov impurities | <2.00% |
Heavy Metals (raws li Pb) | <20 ppm |
Test Standard | Enterprise Standard |
Kev siv | Intermediate ntawm Olmesartan Medoxomil (CAS: 144689-63-4) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
N2-Trityl Olmesartan Acid (CAS: 752179-89-8) yog ib qho nruab nrab hauv kev sib xyaw ntawm Olmesartan Medoxomil (CAS: 144689-63-4) muaj feem xyuam nrog cov tshuaj.Olmesartan Medoxomil yog ib qho angiotensin II receptor antagonist uas tau siv los kho cov ntshav siab.Olmesartan Medoxomil yog ib qho prodrug ntawm Olmesartan, yog angiotensin II hom 1 receptor (AT1) inhibitor uas inhibits kev tswj tsis zoo ntawm renin secretion, txo qis ntawm aldosterone thiab ua rau txo qis peripheral vascular resistance (vasodilation).Cov tshuaj no nthuav tawm antihypertensive, cardioprotective, vasodilatory, thiab tiv thaiv kev ua haujlwm.Olmesartan Medoxomil tuaj yeem siv ib leeg lossis ua ke nrog lwm cov tshuaj tiv thaiv kab mob.Hauv kev sib piv cov kev tshawb fawb soj ntsuam hauv cov neeg mob uas muaj ntshav siab tseem ceeb, Olmesartan txo cov ntshav siab diastolic ntau dua li Losartan, Valdesartan thiab Ibesartan, thaum txo cov ntshav siab systolic zoo ib yam rau txhua txoj kev kho mob.